Efficacy and Safety of Mitiglinide vs Acarbose in Patients With Type 2 Diabetes Mellitus
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 248 participants.
Also called NCT02143765
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 248 participants
- Sponsor
- Registry
-
NCT02143765
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT02143765. Randomized; no masking; primary purpose treatment. Start 2014-05 (registry gives no type); primary completion 2015-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Mitiglinide vs Acarbose in Patients With Type 2 Diabetes Mellitus
- Acronym
- Match-101
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Mitiglinide
- Intervention (Drug)
- Acarbose
- Lead sponsor
- Zhongda Hospital
Record details
- Record id
cardio:ct-nct02143765- Content hash
3bfe1b0d021e14e179f58d6963a32260a1ff9afead66b23288fd8eb006030ac5